|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
136,480,000 |
Market
Cap: |
4.48(B) |
Last
Volume: |
503,160 |
Avg
Vol: |
501,762 |
52
Week Range: |
$26.23 - $39.94 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Related Products |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
S&P 400 MIDCAP |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Perrigo is a provider of over-the-counter health and wellness solutions that can be self-managed. Co.'s segments are as follows: Consumer Self-Care Americas, which is focused primarily on the sale of self-care products in categories including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements; Consumer Self-Care International, which develops, manufactures, markets, and distributes European consumer self-care brands in the upper respiratory, pain and sleep-aids, digestive health, vitamins, minerals and supplements; and Prescription Pharmaceuticals, which develops, manufactures, and markets a portfolio of generic prescription drugs.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Papa Joseph C |
President and CEOChairman |
|
2013-08-27 |
4 |
OE |
$35.85 |
$537,750 |
D/D |
15,000 |
133,455 |
|
- |
|
Farrington Thomas |
Senior VP and CIO |
|
2013-08-26 |
4 |
AS |
$119.30 |
$111,784 |
D/D |
(937) |
1,040 |
|
- |
|
Brown Judy L |
Executive VP & CFO |
|
2013-08-26 |
4 |
AS |
$119.28 |
$408,407 |
D/D |
(3,424) |
17,433 |
|
- |
|
Hendrickson John T |
EVP Global Operations & Supply |
|
2013-08-26 |
4 |
AS |
$119.15 |
$250,103 |
D/D |
(2,099) |
0 |
|
- |
|
Stewart Michael Robert |
Sr. VP Global Human Resources |
|
2013-08-23 |
4/A |
D |
$119.38 |
$56,706 |
D/D |
(475) |
1,855 |
|
- |
|
Hendrickson John T |
EVP Global Operations & Supply |
|
2013-08-23 |
4 |
D |
$119.38 |
$131,318 |
D/D |
(1,100) |
2,099 |
|
- |
|
Hendrickson John T |
EVP Global Operations & Supply |
|
2013-08-23 |
4 |
A |
$119.38 |
$381,897 |
D/D |
3,199 |
3,199 |
|
- |
|
Stewart Michael Robert |
Sr. VP Global Human Resources |
|
2013-08-23 |
4 |
D |
$119.38 |
$52,527 |
D/D |
(440) |
1,890 |
|
- |
|
Stewart Michael Robert |
Sr. VP Global Human Resources |
|
2013-08-23 |
4 |
A |
$119.38 |
$179,189 |
D/D |
1,501 |
2,330 |
|
- |
|
Yu Louis |
Senior VP Global Quality |
|
2013-08-23 |
4 |
D |
$119.38 |
$51,811 |
D/D |
(434) |
10,840 |
|
- |
|
Yu Louis |
Senior VP Global Quality |
|
2013-08-23 |
4 |
A |
$119.38 |
$163,670 |
D/D |
1,371 |
11,274 |
|
- |
|
Shah Jatin |
Sr VP & Chief Scientific Offic |
|
2013-08-23 |
4 |
D |
$119.38 |
$72,583 |
D/D |
(608) |
4,166 |
|
- |
|
Shah Jatin |
Sr VP & Chief Scientific Offic |
|
2013-08-23 |
4 |
A |
$119.38 |
$194,828 |
D/D |
1,632 |
4,774 |
|
- |
|
Papa Joseph C |
President and CEOChairman |
|
2013-08-23 |
4 |
D |
$119.38 |
$1,062,243 |
D/D |
(8,898) |
118,455 |
|
- |
|
Papa Joseph C |
President and CEOChairman |
|
2013-08-23 |
4 |
A |
$119.38 |
$2,299,139 |
D/D |
19,259 |
127,353 |
|
- |
|
Jamison Scott F |
Executive Vice President PBM |
|
2013-08-23 |
4 |
D |
$119.38 |
$20,056 |
D/D |
(168) |
3,579 |
|
- |
|
Jamison Scott F |
Executive Vice President PBM |
|
2013-08-23 |
4 |
A |
$119.38 |
$60,406 |
D/D |
506 |
3,747 |
|
- |
|
Needham Jeffrey |
Sr. VP Commercial Business Dev |
|
2013-08-23 |
4 |
D |
$119.38 |
$92,400 |
D/D |
(774) |
8,171 |
|
- |
|
Needham Jeffrey |
Sr. VP Commercial Business Dev |
|
2013-08-23 |
4 |
A |
$119.38 |
$292,362 |
D/D |
2,449 |
8,945 |
|
- |
|
Kochan Sharon |
Executive VP U.S. Generics |
|
2013-08-23 |
4 |
D |
$119.38 |
$86,789 |
D/D |
(727) |
7,685 |
|
- |
|
Kochan Sharon |
Executive VP U.S. Generics |
|
2013-08-23 |
4 |
A |
$119.38 |
$233,746 |
D/D |
1,958 |
8,412 |
|
- |
|
Kingma Todd W |
Executive VP, General Counsel |
|
2013-08-23 |
4 |
D |
$119.38 |
$289,974 |
D/D |
(2,429) |
19,892 |
|
- |
|
Kingma Todd W |
Executive VP, General Counsel |
|
2013-08-23 |
4 |
A |
$119.38 |
$627,461 |
D/D |
5,256 |
22,321 |
|
- |
|
Brown Judy L |
Executive VP & CFO |
|
2013-08-23 |
4 |
D |
$119.38 |
$351,097 |
D/D |
(2,941) |
20,857 |
|
- |
|
Brown Judy L |
Executive VP & CFO |
|
2013-08-23 |
4 |
A |
$119.38 |
$759,854 |
D/D |
6,365 |
23,798 |
|
- |
|
1400 Records found
|
|
Page 5 of 56 |
|
|